NCT01188603已完成1 期
Evaluation of Single Dose and Steady State Pharmacokinetics of Flibanserin Postmenopausal Women With Hypoactive Sexual Desire Disorder
适应症
干预措施
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 24
- 试验地点
- 4
- 主要终点
- Flibanserin: Area Under the Curve; AUC_0-∞
研究概览
简要总结
This trial examines the way flibanserin is metabolized in postmenopausal women with Hypoactive Sexual Desire Disorder.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究组 & 干预措施
flibanserin
Experimental
flibanserin 100 mg dose every evening
干预措施: flibanserin 100 mg dose every evening (Drug)
结局指标
主要结局
Flibanserin: Area Under the Curve; AUC_0-∞
时间窗: 8 days
Geometric mean of the AUC_0-∞ of Flibanserin
Flibanserin: AUC τ,ss
时间窗: 8 days
Geometric mean of the AUC τ,ss of Flibanserin
Flibanserin: Cmax (Peak Concentration)
时间窗: 8 days
Geometric mean of the Cmax of Flibanserin
Flibanserin: Cmax,ss
时间窗: 8 days
Geometric mean of the Cmax,ss of Flibanserin
Flibanserin: Tmax,ss
时间窗: 8 days
Median of the tmax,ss of Flibanserin
次要结局
未报告次要终点
研究者
研究点 (4)
Loading locations...
相似试验
终止
不适用
Effects of Flibanserin on the Pre- and Post-menopausal Female BrainHypoactive Sexual Desire DisorderNCT02770768University of Chicago57
已完成
2 期
A Clinical Trial to Compare Efficacy and Tolerability of Fulvestrant 250mg, 250mg Plus 250mg Loading Regimen and 500mgMetastatic Breast CancerAdvanced Breast CancerNCT00313170AstraZeneca144
终止
3 期
12 Week Safety Trial of Flibanserin in Depressed Women Taking an SSRI or SNRI With Decreased Sexual Desire and DistressSexual Dysfunctions, PsychologicalDepressionNCT01040208Sprout Pharmaceuticals, Inc111
已完成
2 期
SAKK - a Trial to Evaluate Antitumor Efficacy of Faslodex® After Aromatase Inhibitor Failure in Advanced Breast CancerBreast NeoplasmsNCT00272740AstraZeneca93
已完成
1 期
A Study to Assess the Pharmacokinetics of Camizestrant (AZD9833) When Administered Alone and in Combination With ItraconazoleHealthy SubjectsNCT05551897AstraZeneca14